A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis

Targeting the metastatic process is a critical pursuit in the treatment of malignant disease. There are currently no specific anti‐metastatic drugs approved for clinical use, despite metastasis being the leading cause of death for cancer patients. Targeting the Tie1 receptor was shown as a possible strategy for selective anti‐metastasis therapies based on previous gene deletion studies. This current study is the first description of a human antibody against Tie1 with the potential for clinical use in targeting extravasation of tumor cells into organs such as the lung, without having a detrimental effect on immune cell infiltration.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis ; volume:12 ; number:6 ; year:2020 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 6 (2020) (gesamt 3)

Creator
Khan, Kabir A.
Kerbel, Robert S.

DOI
10.15252/emmm.202012355
URN
urn:nbn:de:101:1-2022062707000621483445
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Khan, Kabir A.
  • Kerbel, Robert S.

Other Objects (12)